NCT02378688View on ClinicalTrials.gov

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Crohn's Disease
Interventions
DRUG

MT-1303

DRUG

Placebo

Trial Locations (11)

Unknown

Investigational site, City Name

Investigational site, City Name

Investigational Site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY